WO1997024382A1 - Foldable intraocular lens materials - Google Patents

Foldable intraocular lens materials Download PDF

Info

Publication number
WO1997024382A1
WO1997024382A1 PCT/SE1996/001722 SE9601722W WO9724382A1 WO 1997024382 A1 WO1997024382 A1 WO 1997024382A1 SE 9601722 W SE9601722 W SE 9601722W WO 9724382 A1 WO9724382 A1 WO 9724382A1
Authority
WO
WIPO (PCT)
Prior art keywords
ofthe
copolymer
intraocular lens
pea
material according
Prior art date
Application number
PCT/SE1996/001722
Other languages
French (fr)
Inventor
Kenn Hodd
Per MÅNSSON
Original Assignee
Pharmacia & Upjohn Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Ab filed Critical Pharmacia & Upjohn Ab
Publication of WO1997024382A1 publication Critical patent/WO1997024382A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/10Esters
    • C08F220/12Esters of monohydric alcohols or phenols
    • C08F220/16Esters of monohydric alcohols or phenols of phenols or of alcohols containing two or more carbon atoms
    • C08F220/18Esters of monohydric alcohols or phenols of phenols or of alcohols containing two or more carbon atoms with acrylic or methacrylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/14Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
    • A61F2/16Intraocular lenses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/16Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • GPHYSICS
    • G02OPTICS
    • G02BOPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B1/00Optical elements characterised by the material of which they are made; Optical coatings for optical elements
    • G02B1/04Optical elements characterised by the material of which they are made; Optical coatings for optical elements made of organic materials, e.g. plastics
    • G02B1/041Lenses
    • G02B1/043Contact lenses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/16Materials or treatment for tissue regeneration for reconstruction of eye parts, e.g. intraocular lens, cornea

Definitions

  • the present invention relates to the field of intraocular lenses and to improved materials based on acrylate polymers, especially copolymers of 2-phenylethylacrylate and 2-phenylethylmethacrylate, to be used in the production of foldable lenses facilitating small incision surgery.
  • IOL intraocular lens
  • silicones Whilst the advantages of elastomeric silicone IOLs is well established, these lenses have some limitations, in particular most silicones have a lower refractive index than PMMA (1.49). A consequence ofthe lower refractive index of silicone elastomers is the requirement for a thicker lens for any given dioptre than is necessary for PMMA. This factor taken together with the high rubber elasticity of silicone lens material, results in the rapid and powerful recovery ofthe folded IOL, which is undesirable in the context of a posterior chamber lens.
  • a typical method of producing such acrylic polymers is by copolymerisation.
  • 2-phenylethylacry late, 2-PEA, and 2-phenylethylmethacrylate, 2-PEMA for use in the manufacture of IOLs.
  • These copolymers have refractive indices close to 1.55, glass transition temperatures (Tg) below 37°C, and an elongation of 200%, and so, in IOL-form, may be folded, and have a reduced thickness for any dioptre when compared with silicone lenses which in most cases have lower refractive indices.
  • This internal opacification arises from vacuoles of upto 2 ⁇ m in length. Vacuoles are formed by the absorption, by a lens, of water from the aqueous humor, surrounding the lens in the eye. The reason for this is most likely that in a hydrophobic polymer like Acrysof absorbed water may phase-separate forming microvacuoles. Such microvacuoles are, or may serve as, the initiation sites for the microcracks, and it is assumed that this causes glistening in Acrosof type materials.
  • monomers such as acrylic acid, methacrylic acid, hydroxyethylacrylate, hydroxyethylmethacrylate, acrylamide, methacrylamide, poly(ethylene glycol) acrylates (PEG-acrylates) and other similar monomers (preferably unsaturated compounds), especially those containing carboxyl-, hydroxyl- sulphate- or sulphonate-, amido- or substituted amino-bearing groups, known to those skilled in the art of polymer chemistry.
  • PEG-acrylates poly(ethylene glycol) acrylates
  • the 2-PEA 2-PEMA copolymer-based materials to be used according to the present invention in the manufacture of IOLs are characterized in that they are made hydrophilic enough to prevent the formation of microvacuoles with subsequent glistening ofthe material. Accordingly, the materials are characterized in that no internal two-phase system is formed in contact with an aqueous solution.
  • the materials have a degree of swelling in the range of from 0,5-10, for instance 1-5, wt% at saturation, i.e. following immersion in isotonic solution at 37 °C for 24 hours.
  • mixtures of 2-PEA and 2-PEMA are combined with one or more hydrophilic monomers, e.g. from the group of compounds referred to above.
  • the mixture ofthree or more monomers may be converted into a tercopolymer, etc., by conventional free radical polymerisation, in bulk, aqueous suspension or emulsion, or in solution in a suitable solvent, such as toluene.
  • the hydrophilic acid monomer such as acrylic and methacrylic acids into the 2-PEA/2-PEMA copolymer system
  • This method involves the synthesis of an acrylic acid/methacrylic acid copolymer, followed by its conversion to desired copolyester.
  • the acrylate monomer constitutes from 60mole% to 99mole% ofthe polymer, while the methacrylate monomer constitutes from 40mole% to about lmole%.
  • Such copolyacids may be prepared in aqueous or benzene (or other aromatic solvent) solution by the free radical polymerisation ofthe component monomers (AA and MAA).
  • Such polyacids may then be, partially, converted to the desired copoly(acrylate-methacrylate ester), which contains residual free carboxyl groups.
  • Many different methods of producing polyesters from polyacids are reported in the literature, for example the poly(acid chloride) or a poly(acid anhydride) may be reacted with an excess ofthe alcohol ofthe alkyl, aryl or alkylaryl group it is intended to substitute for the acid proton.
  • a copolymer of AA and MAA is converted to a copolymer of acryloyl chloride and methacryloyl chloride by reaction with phosphorus pentachloride, phosphoryl chloride or thionyl chloride and a copolymer of 2-PEA and 2-PEMA synthesised from it by reaction with excess of 2-phenylethyl alcohol.
  • the AA/MAA copolymer is converted to a copolymer of mixed acid anhydrides by reacting with acetic anhydride.
  • This mixed anhydride copolymer may then be used to produce the desired copolymer of 2-PEA and 2-PEMA, by reacting it with 2- phenylethyl alcohol.
  • Other methods of preparing esters from carboxylic acids well known to those skilled in the art of organic synthesis may also be adapted for the preparation of copolymers 2-PEA and 2-PEMA, for example, methods involving phase transfer catalysts.
  • the dry AA/MMA copolymer is dissolved in dimethylsulphoxide and reacted with 2-phenylethyl bromide, in the presence of a catalyst, such as l,8-diazabicyclo[5,4,0]-7-undecene.
  • a catalyst such as l,8-diazabicyclo[5,4,0]-7-undecene.
  • the reaction time and temperature are controlled so that substitution ofthe acid groups by 2-phenylethyl groups is in the range 80-99.9mole%, with the residual carboxyl bearing monomer group, the hydrophilic group, present in the range 200- 0.1mole%.
  • An additional alternative method of producing 2-PEA/2-PEMA copolymers of improved hydrophilicity is by their chemical modification.
  • acid groups are introduced by their partial de-esterification by electron beam irradiation, or by treatment with acid or base. Such treatments may be applied to the material in the bulk condition to introduce acrylic and methacrylic acid groups. They are also effective for the surface modification of IOLs produced from 2-PEA/2-PEMA copolymers, allowing for the fixation, covalent coupling of surface treatments, for instance mucopolysaccharides, e.g. hyaluronic acid, chondroitin sulphate or heparin, to improve biocompatibility ofthe IOL, and/or to impede the development of a secondary cataract.
  • mucopolysaccharides e.g. hyaluronic acid, chondroitin sulphate or heparin
  • One method of doing this involving reacting the surface carboxyls with a polyamine, e.g. poly(ethyleneimine) and attachment ofthe mucopolysaccharide, e.g. heparin via a Schiff s base reaction, followed by reduction (se for instance EP 86186).
  • a polyamine e.g. poly(ethyleneimine)
  • attachment ofthe mucopolysaccharide e.g. heparin via a Schiff s base reaction
  • reduction e for instance EP 86186
  • Alternative methods of attachment are also possible including using a poly(ethylene oxide) spacer, or the use of an albumin-heparin conjugate.
  • Yet another method to produce the desired copolymer is to use a 2-phenylethylmethacrylate /styrylmethylmethacrylate/methacrylic acid tercopolymer, such as (I), as the cross-linking agent for a 2-phenylethylacrylate/(meth)acrylic acid elastomer.
  • a 2-phenylethylmethacrylate /styrylmethylmethacrylate/methacrylic acid tercopolymer such as (I)
  • the composition of (I), the cross-linking agent is (a) 2- phenylethylmethacrylate, 80 to 99.9 mole %; (b) a (meth)acrylate bearing a free vinyl group, e.g., a styryi group as shown in (I), or a 2- hydroxy-3-(meth)acrylpropyl group, or allyl group, etc., 0.1 to 20 mole %; and a hydrophilic monomer, such as (meth)acrylic acid, (meth)acrylamide, N,N-dimethyl(meth)acrylamide, or 2- hydroxyethyl(meth)acrylate, 0 to 2 mole %.
  • a hydrophilic monomer such as (meth)acrylic acid, (meth)acrylamide, N,N-dimethyl(meth)acrylamide, or 2- hydroxyethyl(meth)acrylate, 0 to 2 mole %.
  • a sheet material for IOL production 0.1 to 10 weight % of the tercopolymer of type (I), is dissolved in a mixture (99.9 to 90 weight % of combined monomers) of 2-pheny lethyl-acrylate (99.9 to 90 mole %) and a second (meth)acrylate monomer of a hydrophilic nature, such as (meth)acrylic acid, (meth)acrylamide, N,N-dimethyl(meth)acrylamide, or 2-hydroxyethyl(meth)acrylate (0.1 to 10 mole %), together with a free radical initiator, such as benzoyl peroxide, or azobisdiisobutyronitrile (0.025 to 5 weight %).
  • a free radical initiator such as benzoyl peroxide, or azobisdiisobutyronitrile (0.025 to 5 weight %).
  • Such formulations may be converted to cast sheets of cross-linked copoly(2-phenylethyl-acrylate) elastomers by the conventional 2-step procedure.
  • the first step is to prepare a casting syrup by heating the mixture of monomers, cross-linking agent and thermal free radical initiator, at temperatures near to 80°C for 5 to 30 minutes.
  • the second step is to transfer the resulting thick polymerising syrup to a cell suitable for casting sheets, and advance the polymerisation to completion by subjecting the cell to an appropriate heating regime, e.g., 2 to 10 hours at 40 to 80°C followed by 2 to 10 hours at 80 to 140°C.
  • IOLs may be lathe-cut from the resulting sheets, preferably whilst holding the temperature ofthe sheets below 0°C, that is below their T g s.

Abstract

Hydrophilic 2-phenylethylacrylate and 2-phenylethymethacrylate copolymer-based materials for use in the manufacture of introcular lenses with minimized risk for glistening.

Description

Foldable Intraocular Lens Materials.
The present invention relates to the field of intraocular lenses and to improved materials based on acrylate polymers, especially copolymers of 2-phenylethylacrylate and 2-phenylethylmethacrylate, to be used in the production of foldable lenses facilitating small incision surgery.
When an ophthalmic surgeon operates on an eye to remove a cataract (s)he frequently replaces the defective natural lens with a small artificial lens, an intraocular lens (IOL). The material most commonly used for the manufacture of IOLs has for many years been rigid amoφhous plastic poly(methylmethacrylate) (PMMA).
In cataract surgery an incision must be made in the eye in order to remove the natural lens as well as for introducing the IOL. The minimum size of incision necessary to allow the passage of a rigid lens is about the diameter ofthe IOL (5.0-6.0mm) and in the development of such lenses considerable efforts have been focused on the design ofthe haptics to avoid incisions greater than the cross-section ofthe optical part ofthe lens. However, with these comparatively large incisions sutures are needed and the technique may give rise to various wound-related problems including infection, wound leak, and astigmatism.
For some years there have been on the market elastomeric silicone lenses of a design that allows the IOL to be reversibly deformed, for instance folded or rolled-up, prior to insertion, so that the size ofthe incision required is about halved to around 3.0mm. This was preceded by the development ofthe phacoemulsification technique for extra capsular cataract extraction which means that the natural lens can be removed through a small incision. The introduction ofthe smaller wound technique, which eliminates the need for sutures, allows less restricted early postoperative physical activity and more rapid optical rehabilitation.
Whilst the advantages of elastomeric silicone IOLs is well established, these lenses have some limitations, in particular most silicones have a lower refractive index than PMMA (1.49). A consequence ofthe lower refractive index of silicone elastomers is the requirement for a thicker lens for any given dioptre than is necessary for PMMA. This factor taken together with the high rubber elasticity of silicone lens material, results in the rapid and powerful recovery ofthe folded IOL, which is undesirable in the context of a posterior chamber lens.
To overcome some of these disadvantages alternative flexible lens materials have been sought which combine a high refractive index with a lower elasticity. Acrylic polymers have been favoured by some manufacturer of lenses because of their biocompatibility, ease of preparation, high level of atacticity - ensuring low crystallinity and hence high optical clarity, good processing characteristics, and long term stability to UV.
A typical method of producing such acrylic polymers is by copolymerisation. Thus in EP 91310271.1 and US 5290892, to Nestle SA, is reported the preparation of copolymers of 2-phenylethylacry late, 2-PEA, and 2-phenylethylmethacrylate, 2-PEMA, for use in the manufacture of IOLs. These copolymers have refractive indices close to 1.55, glass transition temperatures (Tg) below 37°C, and an elongation of 200%, and so, in IOL-form, may be folded, and have a reduced thickness for any dioptre when compared with silicone lenses which in most cases have lower refractive indices.
Recently it has become apparent that IOLs made from copolymers of 2- PEA and 2-PEMA, exemplified by Acrysof from Alcon, suffer from glistening during their clinical use. This internal opacification arises from vacuoles of upto 2 μm in length. Vacuoles are formed by the absorption, by a lens, of water from the aqueous humor, surrounding the lens in the eye. The reason for this is most likely that in a hydrophobic polymer like Acrysof absorbed water may phase-separate forming microvacuoles. Such microvacuoles are, or may serve as, the initiation sites for the microcracks, and it is assumed that this causes glistening in Acrosof type materials.
Scope ofthe Invention:
We have found that already a small increase in the hydrophilicity ofthe 2-PEA/2-PEMA copolymer-based materials will prevent the internal opacification of lenses made from them. This finding is of course valid even if the mechanism discussed above would be found incomplete or even less correct. The hydrophilicity of these copolymers is improved by introducing, in low molar ratio, in the range 0.1 to 10 mole%, a third monomer of recognised hydrophilic character, e.g. monomers such as acrylic acid, methacrylic acid, hydroxyethylacrylate, hydroxyethylmethacrylate, acrylamide, methacrylamide, poly(ethylene glycol) acrylates (PEG-acrylates) and other similar monomers (preferably unsaturated compounds), especially those containing carboxyl-, hydroxyl- sulphate- or sulphonate-, amido- or substituted amino-bearing groups, known to those skilled in the art of polymer chemistry.
The 2-PEA 2-PEMA copolymer-based materials to be used according to the present invention in the manufacture of IOLs are characterized in that they are made hydrophilic enough to prevent the formation of microvacuoles with subsequent glistening ofthe material. Accordingly, the materials are characterized in that no internal two-phase system is formed in contact with an aqueous solution. The materials have a degree of swelling in the range of from 0,5-10, for instance 1-5, wt% at saturation, i.e. following immersion in isotonic solution at 37 °C for 24 hours.
For the preparation of polymers of improved hydrophilicity for the manufacture of foldable IOLs, mixtures of 2-PEA and 2-PEMA, in the range of molar ratios as described in US 5290892, hereby incorporated by reference, are combined with one or more hydrophilic monomers, e.g. from the group of compounds referred to above. The mixture ofthree or more monomers may be converted into a tercopolymer, etc., by conventional free radical polymerisation, in bulk, aqueous suspension or emulsion, or in solution in a suitable solvent, such as toluene.
An alternative approach to the introduction ofthe hydrophilic acid monomer, such as acrylic and methacrylic acids into the 2-PEA/2-PEMA copolymer system may also be adopted. This method involves the synthesis of an acrylic acid/methacrylic acid copolymer, followed by its conversion to desired copolyester. In such copolymers, the acrylate monomer constitutes from 60mole% to 99mole% ofthe polymer, while the methacrylate monomer constitutes from 40mole% to about lmole%. Preferred are polymers consisting of 90-95mole% acrylic acid, AA, and 10-5mole% methacrylic acid, MAA. Such copolyacids may be prepared in aqueous or benzene (or other aromatic solvent) solution by the free radical polymerisation ofthe component monomers (AA and MAA).
Such polyacids may then be, partially, converted to the desired copoly(acrylate-methacrylate ester), which contains residual free carboxyl groups. Many different methods of producing polyesters from polyacids are reported in the literature, for example the poly(acid chloride) or a poly(acid anhydride) may be reacted with an excess ofthe alcohol ofthe alkyl, aryl or alkylaryl group it is intended to substitute for the acid proton. Thus a copolymer of AA and MAA is converted to a copolymer of acryloyl chloride and methacryloyl chloride by reaction with phosphorus pentachloride, phosphoryl chloride or thionyl chloride and a copolymer of 2-PEA and 2-PEMA synthesised from it by reaction with excess of 2-phenylethyl alcohol.
In an alternative reaction the AA/MAA copolymer is converted to a copolymer of mixed acid anhydrides by reacting with acetic anhydride. This mixed anhydride copolymer may then be used to produce the desired copolymer of 2-PEA and 2-PEMA, by reacting it with 2- phenylethyl alcohol. Other methods of preparing esters from carboxylic acids well known to those skilled in the art of organic synthesis may also be adapted for the preparation of copolymers 2-PEA and 2-PEMA, for example, methods involving phase transfer catalysts.
However, most of these methods do not readily lend themselves to the controlled conversion of AA/MAA copolymers such that a selected molar fraction of carboxylic groups is retained in the 2-PEA and 2- PEMA copolymer, which results. A preferred method of synthesis in this context is the following approach.
The dry AA/MMA copolymer is dissolved in dimethylsulphoxide and reacted with 2-phenylethyl bromide, in the presence ofa catalyst, such as l,8-diazabicyclo[5,4,0]-7-undecene. The reaction time and temperature are controlled so that substitution ofthe acid groups by 2-phenylethyl groups is in the range 80-99.9mole%, with the residual carboxyl bearing monomer group, the hydrophilic group, present in the range 200- 0.1mole%.
An additional alternative method of producing 2-PEA/2-PEMA copolymers of improved hydrophilicity is by their chemical modification. Using 2-PEA/2-PEMA copolymers having a composition in the range as specified in US 5290892 as suitable for the manufacture of IOLs, acid groups are introduced by their partial de-esterification by electron beam irradiation, or by treatment with acid or base. Such treatments may be applied to the material in the bulk condition to introduce acrylic and methacrylic acid groups. They are also effective for the surface modification of IOLs produced from 2-PEA/2-PEMA copolymers, allowing for the fixation, covalent coupling of surface treatments, for instance mucopolysaccharides, e.g. hyaluronic acid, chondroitin sulphate or heparin, to improve biocompatibility ofthe IOL, and/or to impede the development of a secondary cataract.
One method of doing this, involving reacting the surface carboxyls with a polyamine, e.g. poly(ethyleneimine) and attachment ofthe mucopolysaccharide, e.g. heparin via a Schiff s base reaction, followed by reduction (se for instance EP 86186). Alternative methods of attachment are also possible including using a poly(ethylene oxide) spacer, or the use of an albumin-heparin conjugate.
Yet another method to produce the desired copolymer (which will be in this case a graft copolymer) is to use a 2-phenylethylmethacrylate /styrylmethylmethacrylate/methacrylic acid tercopolymer, such as (I), as the cross-linking agent for a 2-phenylethylacrylate/(meth)acrylic acid elastomer.
The composition of (I), the cross-linking agent, is (a) 2- phenylethylmethacrylate, 80 to 99.9 mole %; (b) a (meth)acrylate bearing a free vinyl group, e.g., a styryi group as shown in (I), or a 2- hydroxy-3-(meth)acrylpropyl group, or allyl group, etc., 0.1 to 20 mole %; and a hydrophilic monomer, such as (meth)acrylic acid, (meth)acrylamide, N,N-dimethyl(meth)acrylamide, or 2- hydroxyethyl(meth)acrylate, 0 to 2 mole %.
To produce a sheet material for IOL production, 0.1 to 10 weight % of the tercopolymer of type (I), is dissolved in a mixture (99.9 to 90 weight % of combined monomers) of 2-pheny lethyl-acrylate (99.9 to 90 mole %) and a second (meth)acrylate monomer of a hydrophilic nature, such as (meth)acrylic acid, (meth)acrylamide, N,N-dimethyl(meth)acrylamide, or 2-hydroxyethyl(meth)acrylate (0.1 to 10 mole %), together with a free radical initiator, such as benzoyl peroxide, or azobisdiisobutyronitrile (0.025 to 5 weight %).
Figure imgf000010_0001
2-Phenylethylrrεthacιylate styτylrrEtiιylmettø acid tercopolymBr (I)
Such formulations may be converted to cast sheets of cross-linked copoly(2-phenylethyl-acrylate) elastomers by the conventional 2-step procedure. For this process the first step is to prepare a casting syrup by heating the mixture of monomers, cross-linking agent and thermal free radical initiator, at temperatures near to 80°C for 5 to 30 minutes. Then the second step is to transfer the resulting thick polymerising syrup to a cell suitable for casting sheets, and advance the polymerisation to completion by subjecting the cell to an appropriate heating regime, e.g., 2 to 10 hours at 40 to 80°C followed by 2 to 10 hours at 80 to 140°C. IOLs may be lathe-cut from the resulting sheets, preferably whilst holding the temperature ofthe sheets below 0°C, that is below their Tgs.

Claims

Claims:
1. 2-phenylethylacrylate and 2-phenylethylmethacrylate copolymer- based material for use in the manufacture of intraocular lenses characterized in that the material is hydrophilic.
2. Materials according to claim 1, characterized by 0.5-10, preferrably 0.5-5, % water uptake at saturation.
3. Materials according to any one of claims 1-2 characterized in that a third monomer, containing carboxyl-, hydroxyl-, sulphate, sulphonate, poly(ethylene glycol), amido- or substituted amido- bearing groups, is introduced into the reaction mixture prior to polymerisation.
4. Material according to claim 3 characterized in that it contains carboxyl groups.
5. Material according to claim 1, characterized in that the surface is modified to contain a layer comprising a mucopolysaccharide.
6. Material according to claim 5, characterized in that the muchopolysaccharide is heparin.
7. Intraocular lens prepared from a material according to any one of claims 1-6.
8. Intraocular lens according to claim 7 which further comprises a surface bound substance preventing secondary cataract.
PCT/SE1996/001722 1996-01-02 1996-12-20 Foldable intraocular lens materials WO1997024382A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9600006A SE9600006D0 (en) 1996-01-02 1996-01-02 Foldable intraocular lens materials
SE9600006-2 1996-01-02

Publications (1)

Publication Number Publication Date
WO1997024382A1 true WO1997024382A1 (en) 1997-07-10

Family

ID=20400908

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/SE1996/001722 WO1997024382A1 (en) 1996-01-02 1996-12-20 Foldable intraocular lens materials

Country Status (2)

Country Link
SE (1) SE9600006D0 (en)
WO (1) WO1997024382A1 (en)

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999052571A1 (en) * 1998-04-15 1999-10-21 Alcon Laboratories, Inc. Bicomposite intraocular lens and method for its preparation
WO2000034804A1 (en) * 1998-12-11 2000-06-15 Bausch & Lomb Surgical, Inc. High refractive index hydrogel compositions for ophthalmic implants
US6313187B2 (en) 1998-04-15 2001-11-06 Alcon Manufacturing, Ltd. High refractive index ophthalmic device materials prepared using a post-polymerization cross-linking method
US6353069B1 (en) 1998-04-15 2002-03-05 Alcon Manufacturing, Ltd. High refractive index ophthalmic device materials
US6528602B1 (en) 1999-09-07 2003-03-04 Alcon Universal Ltd. Foldable ophthalmic and otorhinolaryngological device materials
US6541572B2 (en) 1998-04-23 2003-04-01 Alcon Manufacturing, Ltd. Method of making high refractive index ophthalmic device materials
US6635732B2 (en) 1999-04-12 2003-10-21 Surgidev Corporation Water plasticized high refractive index polymer for ophthalmic applications
US6703466B1 (en) * 2001-06-18 2004-03-09 Alcon, Inc. Foldable intraocular lens optics having a glassy surface
EP1885290A2 (en) * 2005-05-27 2008-02-13 Bausch & Lomb Incorporated High refractive-index, hydrophilic monomers and polymers, and ophthalmic devices comprising such polymers
US7354980B1 (en) 2004-03-12 2008-04-08 Key Medical Technologies, Inc. High refractive index polymers for ophthalmic applications
US7446157B2 (en) 2004-12-07 2008-11-04 Key Medical Technologies, Inc. Nanohybrid polymers for ophthalmic applications
US7790824B2 (en) 2007-07-25 2010-09-07 Alcon, Inc. High refractive index ophthalmic device materials
US7799845B2 (en) 2007-10-03 2010-09-21 Alcon, Inc. Ophthalmic and otorhinolaryngological device materials
US7888403B2 (en) 2007-10-05 2011-02-15 Alcon, Inc. Ophthalmic and otorhinolaryngological device materials
US8048154B2 (en) 2007-10-05 2011-11-01 Novartis Ag Ophthalmic and otorhinolaryngological device materials
US8105378B2 (en) 2007-10-02 2012-01-31 Novartis Ag Ophthalmic and otorhinolaryngological device materials containing an alkyl ethoxylate
CN102600502A (en) * 2012-03-16 2012-07-25 无锡蕾明视康科技有限公司 Dynamic zooming artificial lens and preparation method of dynamic zooming artificial lens
US8247511B2 (en) 1999-04-12 2012-08-21 Advanced Vision Science, Inc. Water plasticized high refractive index polymer for ophthalmic applications
US8574292B2 (en) 2007-10-02 2013-11-05 Novartis Ag Ophthalmic and otorhinolaryngological device materials containing an alkylphenol ethoxylate
JP2014506814A (en) * 2011-02-08 2014-03-20 ノバルティス アーゲー Low tack hydrophobic ophthalmic device materials
WO2014106866A1 (en) 2013-01-07 2014-07-10 Council Of Scientific & Industrial Research Flexible, high refractive index hydrophobic copolymer
EP2563449A4 (en) * 2010-04-30 2015-10-21 Ayman Boutros Alloplastic injectable dermal filler and methods of use thereof
US9295691B2 (en) 2007-10-29 2016-03-29 Ayman Boutros Method for repairing or replacing damaged tissue
JP2019210345A (en) * 2018-06-01 2019-12-12 上海富吉医療器械有限公司Shanghai Chartwell Medical Instrument Co., Ltd. Polymer material and intraocular lens

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5080924A (en) * 1989-04-24 1992-01-14 Drexel University Method of making biocompatible, surface modified materials
EP0485197A1 (en) * 1990-11-07 1992-05-13 Nestle S.A. Polymers and their use for ophthalmic lenses
WO1994011764A2 (en) * 1992-11-09 1994-05-26 Allergan, Inc. Polymeric compositions and intraocular lenses made from same
WO1995011279A1 (en) * 1993-10-18 1995-04-27 Alcon Laboratories, Inc. Polymerisable yellow dyes and their use in ophthalmic lenses
WO1996011235A1 (en) * 1994-10-06 1996-04-18 Pharmacia & Upjohn Ab Intraocular lens materials

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5080924A (en) * 1989-04-24 1992-01-14 Drexel University Method of making biocompatible, surface modified materials
EP0485197A1 (en) * 1990-11-07 1992-05-13 Nestle S.A. Polymers and their use for ophthalmic lenses
WO1994011764A2 (en) * 1992-11-09 1994-05-26 Allergan, Inc. Polymeric compositions and intraocular lenses made from same
WO1995011279A1 (en) * 1993-10-18 1995-04-27 Alcon Laboratories, Inc. Polymerisable yellow dyes and their use in ophthalmic lenses
WO1996011235A1 (en) * 1994-10-06 1996-04-18 Pharmacia & Upjohn Ab Intraocular lens materials

Cited By (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6210438B1 (en) 1998-04-15 2001-04-03 Alcon Laboratories, Inc. Bicomposite intraocular lens and method for its preparation
US6313187B2 (en) 1998-04-15 2001-11-06 Alcon Manufacturing, Ltd. High refractive index ophthalmic device materials prepared using a post-polymerization cross-linking method
US6353069B1 (en) 1998-04-15 2002-03-05 Alcon Manufacturing, Ltd. High refractive index ophthalmic device materials
WO1999052571A1 (en) * 1998-04-15 1999-10-21 Alcon Laboratories, Inc. Bicomposite intraocular lens and method for its preparation
US6541572B2 (en) 1998-04-23 2003-04-01 Alcon Manufacturing, Ltd. Method of making high refractive index ophthalmic device materials
US6657032B2 (en) 1998-12-11 2003-12-02 Bausch & Lomb Incorporated High refractive index hydrogel compositions for ophthalmic implants
WO2000034804A1 (en) * 1998-12-11 2000-06-15 Bausch & Lomb Surgical, Inc. High refractive index hydrogel compositions for ophthalmic implants
US6329485B1 (en) 1998-12-11 2001-12-11 Bausch & Lomb Incorporated High refractive index hydrogel compositions for ophthalmic implants
US6673886B2 (en) 1998-12-11 2004-01-06 Bausch & Lomb Incorporated High refractive index hydrogel compositions for ophthalmic implants
US6657030B2 (en) 1998-12-11 2003-12-02 Bausch & Lomb Incorporated High refractive index hydrogel compositions for ophthalmic implants
US7083645B2 (en) 1999-04-12 2006-08-01 Advanced Vision Science, Inc. Water plasticized high refractive index polymer for ophthalmic applications
US6635731B2 (en) 1999-04-12 2003-10-21 Surgidev Corporation Water plasticized high refractive index polymer for ophthalmic applications
US6635732B2 (en) 1999-04-12 2003-10-21 Surgidev Corporation Water plasticized high refractive index polymer for ophthalmic applications
US8247511B2 (en) 1999-04-12 2012-08-21 Advanced Vision Science, Inc. Water plasticized high refractive index polymer for ophthalmic applications
US6653422B2 (en) 1999-09-07 2003-11-25 Alcon Universal Ltd. Foldable ophthalmic and otorhinolaryngological device materials
US6528602B1 (en) 1999-09-07 2003-03-04 Alcon Universal Ltd. Foldable ophthalmic and otorhinolaryngological device materials
US6703466B1 (en) * 2001-06-18 2004-03-09 Alcon, Inc. Foldable intraocular lens optics having a glassy surface
US7354980B1 (en) 2004-03-12 2008-04-08 Key Medical Technologies, Inc. High refractive index polymers for ophthalmic applications
US10421830B2 (en) 2004-12-07 2019-09-24 Key Medical Technologies, Inc. Nanohybrid polymers for ophthalmic applications
US7446157B2 (en) 2004-12-07 2008-11-04 Key Medical Technologies, Inc. Nanohybrid polymers for ophthalmic applications
US7745555B2 (en) 2004-12-07 2010-06-29 Key Medical Technologies, Inc. Nanohybrid polymers for ophthalmic applications
US9056934B2 (en) 2004-12-07 2015-06-16 Key Medical Technologies, Inc. Nanohybrid polymers for ophthalmic applications
US7781496B2 (en) * 2005-05-27 2010-08-24 Bausch & Lomb Incorporated High refractive-index, hydrophilic monomers and polymers, and ophthalmic devices comprising such polymers
EP1885290A2 (en) * 2005-05-27 2008-02-13 Bausch & Lomb Incorporated High refractive-index, hydrophilic monomers and polymers, and ophthalmic devices comprising such polymers
US7790824B2 (en) 2007-07-25 2010-09-07 Alcon, Inc. High refractive index ophthalmic device materials
US8105378B2 (en) 2007-10-02 2012-01-31 Novartis Ag Ophthalmic and otorhinolaryngological device materials containing an alkyl ethoxylate
US8574292B2 (en) 2007-10-02 2013-11-05 Novartis Ag Ophthalmic and otorhinolaryngological device materials containing an alkylphenol ethoxylate
US7799845B2 (en) 2007-10-03 2010-09-21 Alcon, Inc. Ophthalmic and otorhinolaryngological device materials
US8048154B2 (en) 2007-10-05 2011-11-01 Novartis Ag Ophthalmic and otorhinolaryngological device materials
US8163862B2 (en) 2007-10-05 2012-04-24 Novartis Ag Ophthalmic and otorhinolaryngological device materials
US8728157B2 (en) 2007-10-05 2014-05-20 Novartis Ag Ophthalmic and otorhinolaryngological device materials
US7888403B2 (en) 2007-10-05 2011-02-15 Alcon, Inc. Ophthalmic and otorhinolaryngological device materials
US8900297B2 (en) 2007-10-05 2014-12-02 Novartis Ag Ophthalmic and otorhinolaryngological device materials
US9295691B2 (en) 2007-10-29 2016-03-29 Ayman Boutros Method for repairing or replacing damaged tissue
EP2563449A4 (en) * 2010-04-30 2015-10-21 Ayman Boutros Alloplastic injectable dermal filler and methods of use thereof
JP2014506814A (en) * 2011-02-08 2014-03-20 ノバルティス アーゲー Low tack hydrophobic ophthalmic device materials
CN102600502B (en) * 2012-03-16 2015-11-25 廖秀高 Intraocular lens of dynamically changeable Jiao and preparation method thereof
CN102600502A (en) * 2012-03-16 2012-07-25 无锡蕾明视康科技有限公司 Dynamic zooming artificial lens and preparation method of dynamic zooming artificial lens
WO2014106866A1 (en) 2013-01-07 2014-07-10 Council Of Scientific & Industrial Research Flexible, high refractive index hydrophobic copolymer
JP2019210345A (en) * 2018-06-01 2019-12-12 上海富吉医療器械有限公司Shanghai Chartwell Medical Instrument Co., Ltd. Polymer material and intraocular lens

Also Published As

Publication number Publication date
SE9600006D0 (en) 1996-01-02

Similar Documents

Publication Publication Date Title
WO1997024382A1 (en) Foldable intraocular lens materials
USRE36150E (en) Deformable-elastic intraocular lens
US6780899B2 (en) Homopolymers containing stable elasticity inducing crosslinkers and ocular implants made therefrom
US5674960A (en) Flexible high refractive index, cross-linked, acrylic copolymers
EP0485197B1 (en) Polymers and their use for ophthalmic lenses
US5331073A (en) Polymeric compositions and intraocular lenses made from same
JP2007262414A (en) Polymer composition and ophthalmic lens main body
US8470034B2 (en) Hydrophobic acrylic polymer material for an intraocular lens having enhanced flexibility due to the use of a transfer agent
CA1339604C (en) Synthetic intraocular lens swellable in swelling agent and a method for preparation thereof
US5821306A (en) Intraocular lens materials
JP2005531363A (en) Surface modified intraocular lens
KR20010033659A (en) High refractive index ophthalmic device materials
AU661306B2 (en) Deformable-elastic intraocular lens
JP2010512225A (en) Regular polymer systems and intraocular lenses
JP2000516520A (en) Materials used in glaucoma filtration devices
WO2000057213A1 (en) Polymeric material compositions and intraocular lenses made from same
KR100470247B1 (en) High refractive index hydrogels prepared from polymers and copolymers of n-benzyl-n-methylacrylamide
Pusch Strategies of preparing transparent latices with application to the synthesis of transparent hydrogels for intraocular lenses
WO2007109134A2 (en) Intraocular lens implant
JPH0728910B2 (en) Intraocular lens material

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: JP

Ref document number: 97524269

Format of ref document f/p: F

122 Ep: pct application non-entry in european phase